• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging

News
Article

One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.

Leveraging a variety of artificial intelligence (AI) capabilities, the newly launched Voluson Signature 20 and 18 ultrasound devices may significantly enhance efficiency of common ultrasound exams for women.

GE HealthCare, the manufacturer of the Voluson Signature 20 and 18 ultrasound devices, said key efficiencies include:

• a 48 percent time reduction for performing fetal heart assessments due to a fetalHS feature, which provide stepwise AI guidance to identify normal fetal heart anatomy;

New AI-Powered Ultrasound Devices Enhance Efficiency in Women’s Health Imaging

The SonoLyst feature, a suite of automated AI tools available with the newly launched Voluson Signature 20 and 18 ultrasound devices, reportedly facilitates a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG). (Image courtesy of GE HealthCare.)

• a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG) due to the SonoLyst feature, a suite of automated AI tools; and

• a 76 percent keystroke reduction with the automated plane alignment and measurements of the SonoPelvicFloor feature.

"We've seen huge advancements in ultrasound technology, including the use of AI, resulting in a new era of ultrasound scanning. The new Voluson Signature series features innovative tools clinicians can rely on, and the automated functions help reduce work stress and improve workflows," noted Ben Csapo, M.D., a maternal fetal medicine specialist in Graz, Austria.

Related Videos
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Expediting the Management of Incidental Pulmonary Emboli on CT
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2024 MJH Life Sciences

All rights reserved.